NEWS
from Hearing on
Possible Health Effects of Pyridostigmine Bromide
On Persian Gulf War Veterans
Tuesday, November 16, 1999 at 2:00PM
|
C-SPAN broadcast the hearing
live, shown here Health Subcommittee Ranking Democratic member Luis Gutierrez (D-IL)
questioning a panel. |
Oversight
and Investigations Subcommittee Chairman Terry Everett (R-AL), right, questions
witnesses while Health Subcommittee Chairman Cliff Stearns (R-FL), who presided at
the hearing, studies his notes. Between the two chairmen is Health Subcommittee
Counsel Ralph Ibson. |
|
|
C.
Ross Anthony, center, Director of the RAND Center for Military Health Policy Research,
testifies on his organization's research. He was joined at the first panel by Dr. Beatrice Alexandra Golomb, a consultant with RAND, and Dr. Joseph S. Cassells, Project Director, Institute of Medicine, National
Academy of Sciences. |
The second panel featured spokesmen for government agencies.
Testifying were, from left, Mark Brown, Director of the VA's Environmental Agents Service;
Bernard D. Rostker, Special Assistant to the Deputy Secretary of
Defense for Gulf War Illnesses, Department of Defense; Dr. Frances
Murphy, the VA's Acting Deputy Under Secretary for Health; and Dr.
Sue Bailey, Assistant Secretary of Defense for Health Affairs, Department of Defense.
|
|
|
Matthew L. Puglisi, Director of Veterans Affairs and Rehabilitation for The
American Legion, answers a question while Paul Sullivan, Executive
Director, National Gulf War Resource Center, and Denise Nichols,
Vice-Chair, National Vietnam and Gulf War Veterans Coalition listen. |
|
Rep. Steve Buyer (R-IN), foreground, of the Oversight &
Investigations Subcommittee spoke with special authority as a veteran of the Persian Gulf
War. |
|
Rep. Helen Chenoweth-Hage (R-ID) of the Health Subcommittee
pursues a point with one of the panels. |
|